Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Differential efficacy of the TSPO ligands etifoxine and XBD-173 in two rodent models of Multiple Sclerosis.
MRI in the Evaluation of Acute Visual Syndromes.
Cytokine-producing B cells: a translational view on their roles in human and mouse autoimmune diseases.
Trichuris suis ova in relapsing-remitting multiple sclerosis and clinically isolated syndrome (TRIOMS): study protocol for a randomized controlled trial.
Sphingosine 1-Phosphate Receptor 1 as a Useful Target for Treatment of Multiple Sclerosis.
Neurological disorders: Differential methylation in multiple sclerosis.
Activation of NOD2/RIPK2 pathway induces mitochondrial injury to oligodendrocyte precursor cells in vitro and CNS demyelination in vivo.
Feasibility of the Use of Combinatorial Chemokine Arrays to Study Blood and CSF in Multiple Sclerosis.
Curcumin protects axons from degeneration in the setting of local neuroinflammation.
Multiple Sclerosis and the Iranian Revolution: Reply to the Comment by Magzhi et al..
Pragmatic exercise intervention for people with multiple sclerosis (ExIMS Trial): Study protocol for a randomised controlled trial.
The radial diffusivity and magnetization transfer pool size ratio are sensitive markers for demyelination in a rat model of type III multiple sclerosis (MS) lesions.
Adrenal disorders and the paediatric brain: pathophysiological considerations and clinical implications.
Neuropathology of multiple system atrophy: New thoughts about pathogenesis.
Core muscle strength and endurance measures in ambulatory persons with multiple sclerosis: validity and reliability.
The role of IL-17 in CNS diseases.
Brain ageing and disorders of the central nervous system: kynurenines and drug metabolism.
Interferon-Related Depression: A Primer on Mechanisms, Treatment, and Prevention of a Common Clinical Problem.
The fat mass and obesity-associated FTO rs9939609 polymorphism is associated with elevated homocysteine levels in patients with multiple sclerosis screened for vascular risk factors.
Multiple sclerosis in New Zealand Māori.
Reducing clinical trial risk in multiple sclerosis.
Cognitive impairment differs between neuromyelitis optica spectrum disorder and multiple sclerosis.
White matter disease: 'Bright spotty lesions'-a novel NMO-specific MRI feature?
A case of IgM paraproteinemic neuropathy associated with anti-sulfated glucuronic paragloboside (SGPG) IgG antibody without anti-myelin-associated glycoprotein (MAG) activity.
Multiple sclerosis: Scoring system to predict response to IFN-β in patients with multiple sclerosis.

Pages